<DOC>
	<DOCNO>NCT01014247</DOCNO>
	<brief_summary>The aim study investigate effect moxifloxacin QT interval order gain information validity result collect another clinical study test riociguat patient pulmonary arterial hypertension ( PATENT-1 study ) .</brief_summary>
	<brief_title>Influence Moxifloxacin QTc Interval Healthy Subjects Positive Control Validation</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy volunteer Age 1875 year Normal ECG Abnormal ECG Intolerance fluorochinolones</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Moxifloxacin</keyword>
</DOC>